341 related articles for article (PubMed ID: 29305692)
1. CD99 at the crossroads of physiology and pathology.
Pasello M; Manara MC; Scotlandi K
J Cell Commun Signal; 2018 Mar; 12(1):55-68. PubMed ID: 29305692
[TBL] [Abstract][Full Text] [Related]
2. CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling.
Manara MC; Terracciano M; Mancarella C; Sciandra M; Guerzoni C; Pasello M; Grilli A; Zini N; Picci P; Colombo MP; Morrione A; Scotlandi K
Oncotarget; 2016 Nov; 7(48):79925-79942. PubMed ID: 27835596
[TBL] [Abstract][Full Text] [Related]
3. Engagement of CD99 induces apoptosis through a calcineurin-independent pathway in Ewing's sarcoma cells.
Sohn HW; Choi EY; Kim SH; Lee IS; Chung DH; Sung UA; Hwang DH; Cho SS; Jun BH; Jang JJ; Chi JG; Park SH
Am J Pathol; 1998 Dec; 153(6):1937-45. PubMed ID: 9846983
[TBL] [Abstract][Full Text] [Related]
4. Cell Adhesion Molecule CD99 in Cancer Immunotherapy.
Yu F; Liu G; Zhang H; Wang X; Wu Z; Xu Q; Wu Y; Chen D
Curr Mol Med; 2023; 23(10):1028-1036. PubMed ID: 36214301
[TBL] [Abstract][Full Text] [Related]
5. CD99 engagement: an effective therapeutic strategy for Ewing tumors.
Scotlandi K; Baldini N; Cerisano V; Manara MC; Benini S; Serra M; Lollini PL; Nanni P; Nicoletti G; Bernard G; Bernard A; Picci P
Cancer Res; 2000 Sep; 60(18):5134-42. PubMed ID: 11016640
[TBL] [Abstract][Full Text] [Related]
6. CD99 triggering in Ewing sarcoma delivers a lethal signal through p53 pathway reactivation and cooperates with doxorubicin.
Guerzoni C; Fiori V; Terracciano M; Manara MC; Moricoli D; Pasello M; Sciandra M; Nicoletti G; Gellini M; Dominici S; Chiodoni C; Fornasari PM; Lollini PL; Colombo MP; Picci P; Cianfriglia M; Magnani M; Scotlandi K
Clin Cancer Res; 2015 Jan; 21(1):146-56. PubMed ID: 25501132
[TBL] [Abstract][Full Text] [Related]
7. Anti-CD99 Antibody Therapy Triggers Macrophage-Dependent Ewing Cell Death In Vitro and Myeloid Cell Recruitment In Vivo.
O'Neill AF; Nguyen EM; Maldonado ED; Chang MR; Sun J; Zhu Q; Marasco WA
Antibodies (Basel); 2024 Mar; 13(1):. PubMed ID: 38534214
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators.
Cerisano V; Aalto Y; Perdichizzi S; Bernard G; Manara MC; Benini S; Cenacchi G; Preda P; Lattanzi G; Nagy B; Knuutila S; Colombo MP; Bernard A; Picci P; Scotlandi K
Oncogene; 2004 Jul; 23(33):5664-74. PubMed ID: 15184883
[TBL] [Abstract][Full Text] [Related]
9. Targeting CD99 in association with doxorubicin: an effective combined treatment for Ewing's sarcoma.
Scotlandi K; Perdichizzi S; Bernard G; Nicoletti G; Nanni P; Lollini PL; Curti A; Manara MC; Benini S; Bernard A; Picci P
Eur J Cancer; 2006 Jan; 42(1):91-6. PubMed ID: 16326096
[TBL] [Abstract][Full Text] [Related]
10. CD99 signals caspase-independent T cell death.
Pettersen RD; Bernard G; Olafsen MK; Pourtein M; Lie SO
J Immunol; 2001 Apr; 166(8):4931-42. PubMed ID: 11290771
[TBL] [Abstract][Full Text] [Related]
11. Suppression of KCMF1 by constitutive high CD99 expression is involved in the migratory ability of Ewing's sarcoma cells.
Kreppel M; Aryee DN; Schaefer KL; Amann G; Kofler R; Poremba C; Kovar H
Oncogene; 2006 May; 25(19):2795-800. PubMed ID: 16314831
[TBL] [Abstract][Full Text] [Related]
12. CD99 is a therapeutic target on disease stem cells in myeloid malignancies.
Chung SS; Eng WS; Hu W; Khalaj M; Garrett-Bakelman FE; Tavakkoli M; Levine RL; Carroll M; Klimek VM; Melnick AM; Park CY
Sci Transl Med; 2017 Jan; 9(374):. PubMed ID: 28123069
[TBL] [Abstract][Full Text] [Related]
13. CD99 ligation induces intercellular cell adhesion molecule-1 expression and secretion in human gingival fibroblasts.
Krisanaprakornkit S; Chotjumlong P; Pata S; Chruewkamlow N; Reutrakul V; Kasinrerk W
Arch Oral Biol; 2013 Jan; 58(1):82-93. PubMed ID: 22795566
[TBL] [Abstract][Full Text] [Related]
14. CD99 (MIC2) regulates the LFA-1/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion.
Hahn JH; Kim MK; Choi EY; Kim SH; Sohn HW; Ham DI; Chung DH; Kim TJ; Lee WJ; Park CK; Ree HJ; Park SH
J Immunol; 1997 Sep; 159(5):2250-8. PubMed ID: 9278313
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapies in Ewing's sarcoma.
Scotlandi K
Adv Exp Med Biol; 2006; 587():13-22. PubMed ID: 17163152
[TBL] [Abstract][Full Text] [Related]
16. Generation of human single-chain antibody to the CD99 cell surface determinant specifically recognizing Ewing's sarcoma tumor cells.
Gellini M; Ascione A; Flego M; Mallano A; Dupuis ML; Zamboni S; Terrinoni M; D'Alessio V; Manara MC; Scotlandi K; Picci P; Cianfriglia M
Curr Pharm Biotechnol; 2013; 14(4):449-63. PubMed ID: 22335486
[TBL] [Abstract][Full Text] [Related]
17. Targeting Tumor Vascular CD99 Inhibits Tumor Growth.
Huijbers EJM; van der Werf IM; Faber LD; Sialino LD; van der Laan P; Holland HA; Cimpean AM; Thijssen VLJL; van Beijnum JR; Griffioen AW
Front Immunol; 2019; 10():651. PubMed ID: 31001265
[TBL] [Abstract][Full Text] [Related]
18. CD99 tumor associated antigen is a potential target for antibody therapy of T-cell acute lymphoblastic leukemia.
Kotemul K; Kasinrerk W; Takheaw N
Explor Target Antitumor Ther; 2024; 5(1):96-107. PubMed ID: 38468825
[TBL] [Abstract][Full Text] [Related]
19. Epimedokoreanin C, a prenylated flavonoid isolated from
Liu X; Wang S; Zheng H; Liu Q; Shen T; Wang X; Ren D
Am J Cancer Res; 2021; 11(7):3496-3514. PubMed ID: 34354857
[TBL] [Abstract][Full Text] [Related]
20. CD99 monoclonal antibody induce homotypic adhesion of Jurkat cells through protein tyrosine kinase and protein kinase C-dependent pathway.
Kasinrerk W; Tokrasinwit N; Moonsom S; Stockinger H
Immunol Lett; 2000 Jan; 71(1):33-41. PubMed ID: 10709783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
